Risk factors for vertical transmission of Chagas disease: A systematic review and meta-analysis.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 10 01 2021
revised: 15 02 2021
accepted: 16 02 2021
pubmed: 23 2 2021
medline: 3 6 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

Vertical transmission of Trypanosoma cruzi infection from mother to infant accounts for a growing proportion of new Chagas disease cases. However, no systematic reviews of risk factors for T. cruzi vertical transmission have been performed. We performed a systematic review of the literature in PubMed, LILACS, and Embase databases, following PRISMA guidelines. Studies were not excluded based on language, country of origin, or publication date. Our literature review yielded 27 relevant studies examining a wide variety of risk factors, including maternal age, parasitic load, immunologic factors and vector exposure. Several studies suggested that mothers with higher parasitic loads may have a greater risk of vertical transmission. A meta-analysis of 2 studies found a significantly higher parasitic load among transmitting than non-transmitting mothers with T. cruzi infection. A second meta-analysis of 10 studies demonstrated that maternal age was not significantly associated with vertical transmission risk. The literature suggests that high maternal parasitic load may be a risk factor for congenital Chagas disease among infants of T. cruzi seropositive mothers. Given the considerable heterogeneity and risk of bias among current literature, additional studies are warranted to assess potential risk factors for vertical transmission of T. cruzi infection.

Sections du résumé

BACKGROUND BACKGROUND
Vertical transmission of Trypanosoma cruzi infection from mother to infant accounts for a growing proportion of new Chagas disease cases. However, no systematic reviews of risk factors for T. cruzi vertical transmission have been performed.
METHODS METHODS
We performed a systematic review of the literature in PubMed, LILACS, and Embase databases, following PRISMA guidelines. Studies were not excluded based on language, country of origin, or publication date.
RESULTS RESULTS
Our literature review yielded 27 relevant studies examining a wide variety of risk factors, including maternal age, parasitic load, immunologic factors and vector exposure. Several studies suggested that mothers with higher parasitic loads may have a greater risk of vertical transmission. A meta-analysis of 2 studies found a significantly higher parasitic load among transmitting than non-transmitting mothers with T. cruzi infection. A second meta-analysis of 10 studies demonstrated that maternal age was not significantly associated with vertical transmission risk.
CONCLUSIONS CONCLUSIONS
The literature suggests that high maternal parasitic load may be a risk factor for congenital Chagas disease among infants of T. cruzi seropositive mothers. Given the considerable heterogeneity and risk of bias among current literature, additional studies are warranted to assess potential risk factors for vertical transmission of T. cruzi infection.

Identifiants

pubmed: 33618005
pii: S1201-9712(21)00160-0
doi: 10.1016/j.ijid.2021.02.074
pmc: PMC8370023
mid: NIHMS1727177
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-373

Subventions

Organisme : FIC NIH HHS
ID : D43 TW010074
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI113197
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI107028
Pays : United States

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Rev Soc Bras Med Trop. 2020;53:e20190560
pubmed: 32348431
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Clin Infect Dis. 2009 Sep 1;49(5):e52-4
pubmed: 19640226
J Mol Diagn. 2019 Nov;21(6):1095-1105
pubmed: 31450011
Trans R Soc Trop Med Hyg. 2012 Oct;106(10):623-8
pubmed: 22835758
J Infect Dis. 2004 Apr 1;189(7):1274-81
pubmed: 15031797
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Am J Trop Med Hyg. 2010 Nov;83(5):1044-7
pubmed: 21036835
Am J Trop Med Hyg. 2004 Feb;70(2):201-9
pubmed: 14993634
Clin Infect Dis. 2015 Sep 15;61(6):918-26
pubmed: 26063720
PLoS One. 2018 Nov 29;13(11):e0208133
pubmed: 30496249
Clin Infect Dis. 2017 Jul 15;65(2):268-275
pubmed: 28369287
Rev Soc Bras Med Trop. 2005;38 Suppl 2:17-20
pubmed: 16482806
Trop Med Int Health. 2006 May;11(5):628-35
pubmed: 16640615
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):507-9
pubmed: 25993401
Am J Trop Med Hyg. 2018 Feb;98(2):478-485
pubmed: 29210352
Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 27;75(4):279-287
pubmed: 30734707
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312
pubmed: 25411847
BMJ Glob Health. 2018 Oct 11;3(5):e001069
pubmed: 30364393
J Infect Dis. 2017 May 1;215(9):1452-1458
pubmed: 28201741
Front Microbiol. 2019 Jun 07;10:1250
pubmed: 31231337
J Infect Dis. 2016 Apr 15;213(8):1299-306
pubmed: 26597259
Clin Infect Dis. 2021 Jul 15;73(2):e477-e484
pubmed: 32667981
Int J Parasitol. 2007 Oct;37(12):1319-27
pubmed: 17570369
Trop Med Int Health. 2007 Dec;12(12):1498-505
pubmed: 18076558
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
J Immunol. 2016 Jun 1;196(11):4596-602
pubmed: 27183607
Clin Infect Dis. 2013 Feb;56(4):496-502
pubmed: 23097582
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006939
pubmed: 30418976
PLoS Negl Trop Dis. 2011 Oct;5(10):e1250
pubmed: 22039554
Adv Parasitol. 2011;75:19-47
pubmed: 21820550
Am J Trop Med Hyg. 2008 Mar;78(3):499-503
pubmed: 18337349
Curr Neurol Neurosci Rep. 2011 Dec;11(6):536-42
pubmed: 21904918
Pediatrics. 2005 Jun;115(6):e668-72
pubmed: 15930194
Rev Soc Bras Med Trop. 2009 Mar-Apr;42(2):107-9
pubmed: 19448923
PLoS One. 2015 Mar 25;10(3):e0119527
pubmed: 25807498
Clin Infect Dis. 2009 Dec 1;49(11):1667-74
pubmed: 19877966
Acta Trop. 2004 Mar;90(1):65-72
pubmed: 14739025
Lancet. 2019 Apr 13;393(10180):1486-1487
pubmed: 30983574
PLoS Negl Trop Dis. 2013 Aug 01;7(8):e2358
pubmed: 23936581
BJOG. 2014 Jan;121(1):22-33
pubmed: 23924273
Rev Soc Bras Med Trop. 2005;38 Suppl 2:101-4
pubmed: 16482826
Euro Surveill. 2019 Jun;24(26):
pubmed: 31266591
Mem Inst Oswaldo Cruz. 2015 May;110(3):369-76
pubmed: 25993506
Am J Trop Med Hyg. 2012 Nov;87(5):837-42
pubmed: 23033397

Auteurs

Melissa D Klein (MD)

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address: melissa_klein@med.unc.edu.

Alvaro Proaño (A)

Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA, USA.

Sassan Noazin (S)

Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Michael Sciaudone (M)

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.

Robert H Gilman (RH)

Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

Natalie M Bowman (NM)

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address: natalie_bowman@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH